Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akorn, a specialty pharmaceutical company, and an undisclosed healthcare company, have entered into a five-year contract manufacturing supply agreement.
Subscribe to our email newsletter
Under the terms of the five-year agreement, Akorn will be responsible for the manufacturing and supply of the ophthalmic drug product. Akorn is the abbreviated new drug application holder and expects to begin supplying the product in the first half of 2009.
Arthur Przybyl, president and CEO of Akorn, said: “We are very pleased to have been selected as the contract manufacturer for this ophthalmic product. The completion of this agreement represents the fifth new ophthalmic partnership in 2008 for our contract manufacturing business.
“We continue to seek opportunities in ophthalmics, liquid and lyophilized injectable products in order to expand our contract pharmaceutical business segment revenues.”